NEW YORK, June 12 - Genome Quebec, the provincial arm of the Canadian genomics research organization Genome Canada, has appointed Paul L'Archevêque to the position of president and chief executive officer, the organization said Tuesday. 

L'Archevêque, a former vice president for marketing at Glaxo Wellcome, now GlaxoSmithKline, said in a statement he would strive to bridge the private and public sectors in raising money and awareness of genomics in Quebec. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.